EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 178 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | -86.0% | 1,903 | -75.4% | 0.00% | -100.0% |
| Q2 2022 | $50,000 | +78.6% | 7,735 | +1005.0% | 0.00% | +200.0% |
| Q1 2022 | $28,000 | +250.0% | 700 | +250.0% | 0.00% | – |
| Q4 2021 | $8,000 | -74.2% | 200 | -60.0% | 0.00% | -100.0% |
| Q2 2021 | $31,000 | -16.2% | 500 | +25.0% | 0.00% | -50.0% |
| Q1 2021 | $37,000 | -65.4% | 400 | -81.9% | 0.00% | -60.0% |
| Q4 2020 | $107,000 | +161.0% | 2,210 | +452.5% | 0.01% | +66.7% |
| Q3 2020 | $41,000 | – | 400 | +300.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 100 | -98.1% | 0.00% | – |
| Q4 2016 | $11,000 | -72.5% | 5,300 | -74.0% | 0.00% | -100.0% |
| Q3 2016 | $40,000 | -74.7% | 20,400 | -39.1% | 0.00% | -88.9% |
| Q2 2016 | $158,000 | – | 33,500 | +6600.0% | 0.01% | – |
| Q1 2016 | $0 | -100.0% | 500 | +150.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |